Screening for cervical cancer

Authors

  • Джоан К. Мерфи FRCSC, Toronto, Canada
  • Робби Хоулетт Toronto, Canada

DOI:

https://doi.org/10.18370/2309-4117.2013.10.61-67

Keywords:

cervical cancer screening, cytology, Pap-test, human papillomavirus, vaccination

Abstract

Cervical cancer is one of the most common gynecological oncopathology on women. It was shown that cervical cancer can be caused by oncogenic strains of human papillomavirus (HPV). So it is important to timely prevent the disease through regular screening of women (particularly of risk group) and vaccination against HPV.The article contains recommendations Society of Obstetricians and Gynecologists of Canada regarding the regular cytological screening for cervical cancer – its benefits, methods, features and so on.

Author Biographies

Джоан К. Мерфи, FRCSC, Toronto

MD

Робби Хоулетт, Toronto

MSc, OhD

Published

2013-11-14

How to Cite

Мерфи, Д. К., & Хоулетт, Р. (2013). Screening for cervical cancer. REPRODUCTIVE ENDOCRINOLOGY, (10), 61–67. https://doi.org/10.18370/2309-4117.2013.10.61-67

Issue

No. 10 (2013)

Section

Статті

License

Copyright (c) 2014 Джоан К. Мерфи, Робби Хоулетт

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.